India's largest private multi-port operator, Adani Ports and Special Economic Zone Limited, today announced that it has raised Rs 125 crore through the issuance of non-convertible debentures.

Pharma major Lupin Limited announced on Friday about the launch of its Betamethasone Dipropionate ointment USP (augmented), 0.05 per cent, having received an approval from United States Food & Drug Administration (USFDA) earlier. The product would be manufactured at Lupin's Pithampur (Unit 3) facility in India.

Yes bank has won the race by gaining 79.65 per cent whereas; PNGC also reacted surprisingly and gained 9.94 per cent. ITC and Hindustan Uniliver gained 8.20 per cent and 0.95, respectively this week.

The stock of Ultratech Cement Limited has formed a morning doji star candlestick pattern on the daily timeframe. The morning doji star is a reversal candlestick pattern, which is bullish and appears at the end of a downtrend.

The stock of Akzo Nobel India Limited has formed a bullish belt hold candlestick pattern on the daily time frame, which signals a shift in the sentiment from bearish to bullish.

Considering the weekly time frame, the stock of Dabur India Limited has bounced back from the edge of the rising trendline support that is formed by connecting swing lows from March 2018. The reversal from the support is confirmed by the above 50-week average volume.

ICICI Lombard, gained today post hitting a fresh 52-week low on Thursday. At the time of market opening on Friday, the stock was trading at Rs 1,057.05, up by 3.55 per cent. The development is a result of company’s new policy, which included an insurance cover for Coronavirus infected people.

The major purpose of the agreement was the development and operation of Bhuj-Naliya-Vayor rail project under PPP model of Indian Railways. The JV has a shareholding divided on holding pattern of RITES-26 per cent, SPRPL-67.5 per cent and PCM holding for 6.5 per cent.

The market opened in the green on March 20, 2020, overall volumes in futures & options currently stand at 3.54 crore contracts with a turnover of Rs. 18,07,622.66 crore.

On Friday, Dr Reddy's Laboratory informed the bourses that it has launched Pyrimethamine tablets USP, 25 mg, which are therapeutic equivalent and first-wave generic version of Daraprim tablets in US markets. The product is the only rated generic version of Daraprim, which is approved by United States Food & Drug Administration (USFDA).